Are patients to blame for these shortages?

Medication shortages originate with manufacturers. Patients are not to blame for these shortages, especially patients with obesity. GLP-1s are approved by the FDA for obesity treatment, and taking these medications for one of their indicated uses is not vanity treatment. Obesity is a chronic disease with far-reaching impacts on overall health, and people with obesity are just as deserving of medication as people with diabetes.